Table 4. Agreement between reference and 3D multi-contrast imaging in identifying plaque components.
3D | Reference | |||||||
---|---|---|---|---|---|---|---|---|
LRNC | CA | IPH | ||||||
Presence | Absence | Presence | Absence | Presence | Absence | |||
Presence† | 73.08 (19/26) | 7.70 (2/26) | 38.46 (10/26) | 3.85 (1/26) | 34.62 (9/26) | 0 (0/26) | ||
Absence† | 3.85 (1/26) | 15.38 (4/26) | 11.54 (3/26) | 46.15 (12/26) | 0 (0/26) | 65.38 (17/26) | ||
Cohen κ (95% CI) | 0.66 (0.30–1.00) | 0.69 (0.42–0.97) | 1.00 (1.00–1.00) |
†Data are percentages, with numbers used to calculate the percentages in parentheses. LRNC, lipid-rich necrotic core; CA, calcification; IPH, intraplaque hemorrhage.